Tomas Castro-Dopico

7PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 20, 2026
Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

|Jan 02, 2026
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity.

Kok Haw Jonathan Lim, Oliver Schulz, Irene Lobon

|Oct 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation.

Michael D Buck, Tomás Castro-Dopico, Oliver Schulz

|Apr 25, 2024
Vitamin D regulates microbiome-dependent cancer immunity.

Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam

|Feb 22, 2022
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity.

Mathieu Uzzan, Jerome C Martin, Luka Mesin

|Jun 17, 2020
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis.

Chenzhi Jing, Tomas Castro-Dopico, Nathan Richoz

Pageof 2

Frequent Collaborators

4 joint publications

Neil C Rogers

4 joint publications

Caetano Reis e Sousa

4 joint publications

Michael D Buck

3 joint publications

William Stainier